Inqovi savings card: $0 a prescription with commercial insurance

How to pay the least

Ask for the cash price

Inqovi

We didn’t find one.

Ask your pharmacy for Inqovi’s cash price, and one or two other pharmacies too.
Inqovi’s savings card works only with insurance from a job or one you bought.

Compare every option

Brand nameInqovi

Authorized genericcedazuridine and decitabine

Regular genericcedazuridine and decitabine

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldNone found

Same as Inqovi?

The original

–

Brand nameThe maker’s card

Taiho Oncology Patient Support (INQOVI $0 Co-Pay Program)

Savings card from Taiho Pharmaceutical (Taiho Oncology)

No insuranceNeeds insuranceNo cash price listed.

Insurance $0 a prescription

Or call 1-844-824-4648.

In the maker’s words

“$0 Co-Pay Program if you have certain private insurance…”

From the maker’s offer on inqovi.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Inqovi itself, from the same company, sold without the brand name, and usually for less. For now Inqovi is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

INQOVI is a combination of decitabine, a nucleoside metabolic inhibitor, and cedazuridine, a cytidine deaminase inhibitor, indicated:

For treatment of adult patients with myelodysplastic syndromes (MDS), including previously treated and untreated, de novo and secondary MDS with the following French-American-British subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, and chronic myelomonocytic leukemia [CMML]) and intermediate-1, intermediate-2, and high-risk International Prognostic Scoring System groups.
In combination with venetoclax for the treatment of newly diagnosed acute myeloid leukemia (AML) in adults 75 years or older, or who have comorbidities that preclude use of intensive induction chemotherapy.

Source: the FDA label for Inqovi (Taiho Pharmaceutical Co., Ltd.), May 25, 2026. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/inqovi/